Skip to main content
NCBI home page
Journal of Clinical Pathology. Supplement (Royal College of Pathologists) logoLink to Journal of Clinical Pathology. Supplement (Royal College of Pathologists)
. 1979;13:126–129. doi: 10.1136/jcp.s3-13.1.126

Therapeutic aspects. Immunosuppression in established humoral responses.

R F Gagnon, I C MacLennan
PMCID: PMC1521580  PMID: 160421

Full text

PDF
126

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barratt T. M., Soothill J. F. Controlled trial of cyclophosphamide in steroid-sensitive relapsing nephrotic syndrome of childhood. Lancet. 1970 Sep 5;2(7671):479–482. doi: 10.1016/s0140-6736(70)90108-x. [DOI] [PubMed] [Google Scholar]
  2. Bowen G. E., Irons G. V., Jr, Rhodes J. B., Kirsner J. B. Early experiences with azathioprine in ulcerative colitis; a note of caution. JAMA. 1966 Feb 7;195(6):460–464. [PubMed] [Google Scholar]
  3. Campbell A. C., Skinner J. M., Hersey P., Roberts-Thomson P., MacLennan I. C., Truelove S. C. Immunosuppression in the treatment of inflammatory bowel disease. I. Changes in lymphoid sub-populations in the blood and rectal mucosa following cessation of treatment with azathioprine. Clin Exp Immunol. 1974 Apr;16(4):521–533. [PMC free article] [PubMed] [Google Scholar]
  4. Campbell A. C., Skinner J. M., Maclennan I. C., Hersey P., Waller C. A., Wood J., Jewell D. P., Truelove S. C. Immunosuppression in the treatment of inflammatory bowel disease. II. The effects of azathioprine on lymphoid cell populations in a double blind trial in ulcerative colitis. Clin Exp Immunol. 1976 May;24(2):249–258. [PMC free article] [PubMed] [Google Scholar]
  5. Caprilli R., Badalamenti G., De Santis R. Rilievi su la terapia della "proctocolite idiopatica" con farmaci immunodepressori. Policlinico Med. 1966 Dec;73(6):349–360. [PubMed] [Google Scholar]
  6. Decker J. L., Klippel J. H., Plotz P. H., Steinberg A. D. Cyclophosphamide or azathioprine in lupus glomerulonephritis. A controlled trial: results at 28 months. Ann Intern Med. 1975 Nov;83(5):606–615. doi: 10.7326/0003-4819-83-5-606. [DOI] [PubMed] [Google Scholar]
  7. Donadio J. V., Jr, Holley K. E., Ferguson R. H., Ilstrup D. M. Progressive lupus glomerulonephritis. Treatment with prednisone and combined prednisone and cyclophosphamide. Mayo Clin Proc. 1976 Aug;51(8):484–494. [PubMed] [Google Scholar]
  8. Donadio J. V., Jr, Holley K. E., Ferguson R. H., Ilstrup D. M. Treatment of diffuse proliferative lupus nephritis with prednisone and combined prednisone and cyclophosphamide. N Engl J Med. 1978 Nov 23;299(21):1151–1155. doi: 10.1056/NEJM197811232992102. [DOI] [PubMed] [Google Scholar]
  9. Gagnon R. F., MacLennan I. C. Regulation of secondary antibody responses in rodents. I. Potentiation of IgG production by cyclophosphamide. Clin Exp Immunol. 1979 Jul;37(1):89–97. [PMC free article] [PubMed] [Google Scholar]
  10. Hawkins D., Cochrane C. G. Glomerular basement membrane damage in immunological glomerulonephritis. Immunology. 1968 May;14(5):665–681. [PMC free article] [PubMed] [Google Scholar]
  11. Hoffsten P. E., Dixon F. J. Effect of irradiation and cyclophosphamide on anti-KLH antibody formation in mice. J Immunol. 1974 Feb;112(2):564–572. [PubMed] [Google Scholar]
  12. Hughes G. R. Significance of anti-D.N.A. antibodies in systemic lupus erythematosus. Lancet. 1971 Oct 16;2(7729):861–863. doi: 10.1016/s0140-6736(71)90234-0. [DOI] [PubMed] [Google Scholar]
  13. Jaffe E. C., Lehner T. Treatment of herpetic stomatitis with idoxuridine. Br Dent J. 1968 Nov 5;124(9):392–395. [PubMed] [Google Scholar]
  14. Jewell D. P., Truelove S. C. Azathioprine in ulcerative colitis: final report on controlled therapeutic trial. Br Med J. 1974 Dec 14;4(5945):627–630. doi: 10.1136/bmj.4.5945.627. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. LEVIN R. H., LANDY M., FREI E., 3rd THE EFFECT OF 6-MERCAPTOPURINE ON IMMUNE RESPONSE IN MAN. N Engl J Med. 1964 Jul 2;271:16–22. doi: 10.1056/NEJM196407022710103. [DOI] [PubMed] [Google Scholar]
  16. Mackay I. R., Wall A. J., Goldstein G. Response to azathioprine in ulcerative colitis. Report of 7 cases. Am J Dig Dis. 1966 Jul;11(7):536–545. doi: 10.1007/BF02233565. [DOI] [PubMed] [Google Scholar]
  17. Naish P. F., Thomson N. M., Simpson I. J., Peters D. K. The role of polymorphonuclear leucocytes in the autologous phase of nephrotoxic nephritis. Clin Exp Immunol. 1975 Oct;22(1):102–111. [PMC free article] [PubMed] [Google Scholar]
  18. Peto R., Pike M. C., Armitage P., Breslow N. E., Cox D. R., Howard S. V., Mantel N., McPherson K., Peto J., Smith P. G. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design. Br J Cancer. 1976 Dec;34(6):585–612. doi: 10.1038/bjc.1976.220. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Peto R., Pike M. C., Armitage P., Breslow N. E., Cox D. R., Howard S. V., Mantel N., McPherson K., Peto J., Smith P. G. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. Br J Cancer. 1977 Jan;35(1):1–39. doi: 10.1038/bjc.1977.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Pincus T., Hughes G. R., Pincus D., Tina L. U., Bellanti J. A. Antibodies to DNA in childhood systemic lupus erythematosus. J Pediatr. 1971 Jun;78(6):981–984. doi: 10.1016/s0022-3476(71)80427-4. [DOI] [PubMed] [Google Scholar]
  21. REBUCK J. W., MELLINGER R. C. Interruption by topical cortisone of leukocytic cycles in acute inflammation in man. Ann N Y Acad Sci. 1953 Jul 17;56(4):715–732. doi: 10.1111/j.1749-6632.1953.tb27394.x. [DOI] [PubMed] [Google Scholar]
  22. Santos G. W. Symposium on immunosuppressive drugs. Immunosuppressive drugs. I. Fed Proc. 1967 May-Jun;26(3):907–913. [PubMed] [Google Scholar]
  23. Soothill J. F., Steward M. W. The immunopathological significance of the heterogeneity of antibody affinity. Clin Exp Immunol. 1971 Aug;9(2):193–199. [PMC free article] [PubMed] [Google Scholar]
  24. Steward M. W., Alpers J. H., Soothill J. F. The effect of cyclophosphamide on the antibody response. Proc R Soc Med. 1973 Aug;66(8):808–810. doi: 10.1177/003591577306600838. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. TALIAFERRO W. H., TALIAFERRO L. G., JANSSEN E. F. The localization of x-ray injury to the initial phases of antibody response. J Infect Dis. 1952 Sep-Oct;91(2):105–124. doi: 10.1093/infdis/91.2.105. [DOI] [PubMed] [Google Scholar]
  26. Theodor E., Gilon E., Waks U. Treatment of ulcerative colitis with azathioprine. Br Med J. 1968 Dec 21;4(5633):741–743. doi: 10.1136/bmj.4.5633.741. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Wagner L. Immunosuppressive agents in lupus nephritis: a critical analysis. Medicine (Baltimore) 1976 May;55(3):239–250. doi: 10.1097/00005792-197605000-00003. [DOI] [PubMed] [Google Scholar]
  28. Waller C. A., MacLennan I. C., Campbell A. C., Festenstein M., Kay H. E. Analysis of treatment in childhood leukaemia. III. Independence of lymphopenia induced by irradiation and by chemotherapy. Br J Haematol. 1977 Apr;35(4):597–612. doi: 10.1111/j.1365-2141.1977.tb00624.x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology. Supplement (Royal College of Pathologists). are provided here courtesy of BMJ Publishing Group

RESOURCES